- XRP eyes global role as “World’s Reserve Bridge Currency,” backed by institutional interest.
- XRP price hits $3.18 with $188B market cap despite a sharp 49% drop in trading volume.
- Wellgistics Health’s XRPL adoption sparks debate over crypto use in healthcare finance.
Oliver Michel, CEO of a major German blockchain venture capital firm, has stated that XRP could become the “World’s Reserve Bridge Currency.” With international trade and financial systems demanding faster and more cost-efficient cross-border payments, XRP is increasingly being considered as a key instrument to bridge traditional banking networks with blockchain-based infrastructure.
The statement aligns with the broader trend of institutional exploration of blockchain for real-time settlements. As demand for cross-border efficiency rises, XRP’s positioning as a high-liquidity asset with proven transaction speed places it under closer watch by both enterprises and market participants.
XRP Price Movement and Market Metrics
XRP traded at $3.18 during the time of writing, posting a 4% gain over 24 hours. The price rally pushed its market capitalization to $188.49 billion, marking the same percentage increase. Despite the price advance, 24-hour trading volume fell 49.13% to $4.67 billion, bringing the volume-to-market-cap ratio down to 2.47%.
The token opened near $3.05 and climbed throughout the session. It consolidated during late trading hours before breaking higher, touching the $3.20 level. Intraday charts showed higher highs and higher lows, reflecting ongoing buyer control even as activity thinned. Circulating supply remained at 59.23 billion XRP out of a total supply of 99.98 billion.
Healthcare Startup Adoption Sparks Debate
XRP’s market momentum coincides with a new development in the healthcare sector. Wellgistics Health, a Nasdaq-listed pharmaceutical startup, has adopted the XRP Ledger (XRPL) for selected financial and operational processes. The small-revenue money-losing firm has revealed that it would use XRP to conduct treasury operations and liquidity analysis.
This action attracted mixed feelings among the legal luminaries. Bill Morgan, a blockchain legal advocate, positively discussed such adoption as a sign of actual business usefulness. On the other hand, another former SEC lawyer, Marc Fagel, noted the financial rationale behind the decision based on his experience with securities regulation. He questioned the dangers of having a healthcare company with cryptocurrency holdings with a narrow budget.
